Yang Zhou1, Melinda L Irwin2, Leah M Ferrucci2, Ruth McCorkle3, Elizabeth A Ercolano4, Fangyong Li5, Kevin Stein6, Brenda Cartmel2. 1. Yale Cancer Center, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States. Electronic address: yang.zhou@yale.edu. 2. Yale Cancer Center, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States. 3. Yale Cancer Center, New Haven, CT, United States; School of Nursing, Yale University, New Haven, CT, United States. 4. School of Nursing, Yale University, New Haven, CT, United States. 5. Yale School of Public Health, New Haven, CT, United States. 6. Behavioral Research Center, American Cancer Society, Atlanta, GA, United States.
Abstract
OBJECTIVE: There are limited data on outcomes and predictors of health-related quality of life (HRQOL) of ovarian cancer survivors. Therefore, we examined the trajectory and predictors of HRQOL one- and two-years post-diagnosis in this population. METHODS: 365 ovarian cancer survivors, a subset of participants in the longitudinal American Cancer Society's Study of Cancer Survivors-I, completed questionnaires at one-year post-diagnosis on sociodemographics, clinical factors, and HRQOL (SF-36). 284 women had HRQOL data at two-years post-diagnosis. In this secondary data analysis, we examined HRQOL at both time points, changes in HRQOL and predictors of HRQOL with univariate and multivariate linear regression. RESULTS: Mean mental and physical HRQOL scores one-year post-diagnosis were 49.37 (SD±11.59) and 45.96 (SD±10.89), respectively. Older age, lower income, higher disease stage, more comorbidities and greater symptom burden were associated with poorer physical functioning one year post-diagnosis. Younger age, higher stage, having an existing mental health issue, greater symptom burden, and not receiving chemotherapy were associated with poorer mental functioning. Disease recurrence between one- and two-years post-diagnosis and greater symptom burden were predictors of declining physical functioning from one- to two-years post-diagnosis. Mental functioning did not change significantly between assessments. CONCLUSIONS: Overall mental and physical functioning of these ovarian cancer survivors was similar to the general population. However, lower HRQOL was associated with a number of variables, including disease recurrence, treatment status, symptom burden, age, and number of comorbidities. These findings can help health care providers identify survivors who may benefit from relevant interventions.
OBJECTIVE: There are limited data on outcomes and predictors of health-related quality of life (HRQOL) of ovarian cancer survivors. Therefore, we examined the trajectory and predictors of HRQOL one- and two-years post-diagnosis in this population. METHODS: 365 ovarian cancer survivors, a subset of participants in the longitudinal American Cancer Society's Study of Cancer Survivors-I, completed questionnaires at one-year post-diagnosis on sociodemographics, clinical factors, and HRQOL (SF-36). 284 women had HRQOL data at two-years post-diagnosis. In this secondary data analysis, we examined HRQOL at both time points, changes in HRQOL and predictors of HRQOL with univariate and multivariate linear regression. RESULTS: Mean mental and physical HRQOL scores one-year post-diagnosis were 49.37 (SD±11.59) and 45.96 (SD±10.89), respectively. Older age, lower income, higher disease stage, more comorbidities and greater symptom burden were associated with poorer physical functioning one year post-diagnosis. Younger age, higher stage, having an existing mental health issue, greater symptom burden, and not receiving chemotherapy were associated with poorer mental functioning. Disease recurrence between one- and two-years post-diagnosis and greater symptom burden were predictors of declining physical functioning from one- to two-years post-diagnosis. Mental functioning did not change significantly between assessments. CONCLUSIONS: Overall mental and physical functioning of these ovarian cancer survivors was similar to the general population. However, lower HRQOL was associated with a number of variables, including disease recurrence, treatment status, symptom burden, age, and number of comorbidities. These findings can help health care providers identify survivors who may benefit from relevant interventions.
Authors: G Bifulco; N De Rosa; M L Tornesello; R Piccoli; A Bertrando; G Lavitola; I Morra; A Di Spiezio Sardo; F M Buonaguro; C Nappi Journal: Gynecol Oncol Date: 2011-11-23 Impact factor: 5.482
Authors: Tenbroeck Smith; Kevin D Stein; C Christina Mehta; Chiewkwei Kaw; James L Kepner; Trent Buskirk; Jeremy Stafford; Frank Baker Journal: Cancer Date: 2007-01-01 Impact factor: 6.860
Authors: Samith Sandadi; Heidi E Frasure; Meredith J Broderick; Steven E Waggoner; Jacqualin A Miller; Vivian E von Gruenigen Journal: Gynecol Oncol Date: 2011-11 Impact factor: 5.482
Authors: Susan K Lutgendorf; Barrie Anderson; Philip Ullrich; Erica L Johnsen; Richard E Buller; Anil K Sood; Joel I Sorosky; Justine Ritchie Journal: Cancer Date: 2002-01-01 Impact factor: 6.860
Authors: Abdel W Awadalla; Jude U Ohaeri; Abdullah Gholoum; Ahmed O A Khalid; Hussein M A Hamad; Anila Jacob Journal: BMC Cancer Date: 2007-06-19 Impact factor: 4.430
Authors: Christelle Schofield; Robert U Newton; Paul A Cohen; Daniel A Galvão; Joanne A McVeigh; Ganendra R Mohan; Jason Tan; Stuart G Salfinger; Leon M Straker; Carolyn J Peddle-McIntyre Journal: Support Care Cancer Date: 2018-02-01 Impact factor: 3.603
Authors: Brian D Gonzalez; Sharon L Manne; Jerod Stapleton; Shannon Myers-Virtue; Melissa Ozga; David Kissane; Carolyn Heckman; Mark Morgan Journal: Support Care Cancer Date: 2016-10-19 Impact factor: 3.603
Authors: Roger T Anderson; Lauren C Peres; Fabian Camacho; Elisa V Bandera; Ellen Funkhouser; Patricia G Moorman; Lisa E Paddock; Edward S Peters; Sarah E Abbott; Anthony J Alberg; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ann G Schwartz; Paul Terry; Joellen M Schildkraut Journal: J Womens Health (Larchmt) Date: 2018-10-10 Impact factor: 2.681
Authors: Mackenzi Pergolotti; Antoine Bailliard; Lauren McCarthy; Erica Farley; Kelley R Covington; Kemi M Doll Journal: Am J Occup Ther Date: 2020 May/Jun